entertainment -WSS

entertainment

author：explore 2025-08-26 01:32:49 - browse：8476

Adobe

WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Study finds gene variants tied to breast cancer risk in Black women

WSS

A new initiative will help leaders fight the next pandemic

Eli Lilly’s Zepbound improved liver scarring in mid

UnitedHealth argues against case alleging wrongful AI care denials

Eyeing GLP

How CO2 helps viruses stay alive longer in the air

Data don't support strong claims for Covid

hotspot

entertainment

entertainment

Guidelines to prevent youth baseball injuries need more muscle

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Hepatitis C has a cure — but many Americans still lack access to it

Congress needs to close a vaccine

Wildfire smoke exposes gaps in outdoor worker protections

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Psychedelics group wrestles with new pharma identity

ASCO Daily Recap: CAR

Anesthesiologist group: stop taking Ozempic before surgery

Finland to offer bird flu vaccine to select groups of people, a possible global first

hotspot

Making the case for fair compensation in clinical trials

Structure Therapeutics oral GLP

Finland to offer bird flu vaccine to select groups of people, a possible global first

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Data don't support strong claims for Covid

Listen: A conversation with researcher Kevin Esvelt on biosecurity

explore

hotspot

hotspot

focus